NCT02192359 Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02101905 Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma Status COMPLETED Phase PHASE1
NCT02017717 A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients Status COMPLETED Phase PHASE3
NCT01925573 Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344) Status TERMINATED Phase NA
NCT01904123 STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain Status COMPLETED Phase PHASE1
NCT01849146 Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT01830101 A Phase III Study of Re-Irradiation in Recurrent Glioblastoma Status WITHDRAWN Phase PHASE3
NCT01814813 Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT01754350 Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma Status COMPLETED Phase NA
NCT01609790 Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors Status COMPLETED Phase PHASE2
NCT01498328 A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Status COMPLETED Phase PHASE2
NCT01349036 A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma Status TERMINATED Phase PHASE2
NCT01266031 Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT00777153 Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma Status COMPLETED Phase PHASE3
NCT00586508 Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas Status COMPLETED Phase PHASE2